160 results on '"Rudek M"'
Search Results
2. Contact atomic force microscopy using piezoresistive cantilevers in load force modulation mode
3. 3D RECONSTRUCTION BASED ON PHOTOGRAMMETRY FOR MIXED REALITY IN INTERACTIVE SIMULATION VIRTUAL ENVIRONMENTS
4. Off-label, but on target:the evidence needed to implement alternative dosing regimens of anticancer drugs
5. Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
6. A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias
7. Sorafenib Dose Escalation Is Not Uniformly Associated With Blood Pressure Elevations in Normotensive Patients With Advanced Malignancies
8. Pharmacotherapy in Cancer Patients With HIV/AIDS
9. Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay
10. 1833P Concurrent high-dose IV Vitamin C (IVC) and docetaxel for metastatic castrate-resistant prostate cancer (mCRPC): A randomized, placebo-controlled, double-blind phase II trial
11. High-dose administration of tyrosine kinase inhibitors to improve clinical benefit: A systematic review
12. Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen
13. SELEÇÃO DE SOFTWARE BASEADA EM AHP PARA CRIAÇÃO DE DATASET SINTÉTICO 3D
14. SUPORTE À TOMADA DE DECISÃO NO PROCESSO ASSISTIDO DE IMPLANTES DENTÁRIOS: UMA REVISÃO DA LITERATURA E ANÁLISE DE CONTEÚDO
15. AUTOMATED 3D BONE MODELLING BASED ON GEOMETRIC FEATURES FROM IMAGES
16. 42 Poster Discussion - Tumor drug exposure is positively correlated with an improved outcome, in patients with advanced solid tumors, upon treatment with a high dose intermittent sunitinib regimen
17. Irinotecan-eluting LC Bead-M1 (DEBIRI-M1) for patients with liver metastases from colorectal cancer: a phase II single-center study
18. P-300: Gait pattern visualization in geriatric patients using a displacement measurement of distributed centres of pressure
19. TR-09 * THE EFFECT OF REGADENOSON-INDUCED TRANSIENT DISRUPTION OF THE BLOOD BRAIN BARRIER ON TEMOZOLOMIDE DELIVERY TO RAT BRAIN PARENCHYMA
20. Abstract No. 368 - Irinotecan-eluting LC Bead-M1 (DEBIRI-M1) for patients with liver metastases from colorectal cancer: a phase II single-center study
21. A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours
22. ARMScope – the versatile platform for scanning probe microscopy systems
23. The individualisation of cancer therapy in organ dysfunction
24. Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis
25. The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients
26. Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
27. Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
28. Local delivery of rapamycin: a toxicity and efficacy study in an experimental malignant glioma model in rats
29. AIDS malignancy consortium (AMC) study 061: A phase I/PK study of sunitinib (S) with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors.
30. A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC).
31. Tolerance of full-dose sorafenib (S) combined with irinotecan (I; weekly, two on, one off) and cetuximab (C) in previously treated patients with advanced colorectal cancer (CRC).
32. Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
33. Geometric modeling from the medical images in the CAD system to support prosthesis design
34. Methodology proposal for acquisition of biotelemetric data in a real time
35. Treating HIV+ patients for non-AIDS-defining cancers (NADCs) in the era of targeted chemotherapy: An AIDS malignancy consortium study of sunitinib in patients on ART.
36. Phase II study of neoadjuvant and adjuvant gefitinib (G) with neoadjuvant chemoradiotherapy (CRT) in operable esophageal adenocarcinoma (EAC).
37. Preclinical identification of biomarkers of response to mTOR inhibitors and subsequent application in a phase II trial of sirolimus in pancreatic cancer patients refractory to gemcitabine
38. Single nucleotide polymorphisms of TSER, ATM, RecQ1 genes association with survival in pancrease cancer
39. Pharmacodynamic (PD) study of pre-prostatectomy rapamycin in men with advanced localized prostate cancer (PC): A DOD Prostate Cancer Clinical Trials Consortium Trial
40. A phase I study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women with breast cancer
41. Effect of simvastatin on the pharmacokinetics of anastrozole
42. Integrated development of s-trans, trans-farnesylthiosalicyclic acid (FTS, salirasib) in advanced pancreatic cancer
43. Phase I dose escalation trial of sorafenib as a single agent for adults with relapsed and refractory acute leukemias
44. Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC)
45. Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay
46. Microdialysis to Measure Radiation-induced Blood-brain Barrier Disruption in Mice
47. A Phase I Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib (E) and Capecitabine (Cap) with Concurrent Radiation (RT) in Resected Pancreatic Cancer (PanCa)
48. Determination of salirasib (S-trans,trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography–tandem mass spectrometry
49. Phase I first-in-human study of s-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors
50. Phase I trial of 5-azacitidine (5AC) and SNDX-275 in advanced lung cancer (NSCLC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.